Chuanhe B. Jiang

168 Changhai Road
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Concurrent BCR::ABL1 and CBFA2T3::GLIS2 fusions in an adult patient with acute leukaemia.

Concurrent BCR::ABL1 and CBFA2T3::GLIS2 fusions in an adult patient with acute leukaemia.

Journal: The Lancet. Haematology

Published: March 13, 2026

Donor-derived distinct neutrophil subsets in the G-CSF-mobilized peripheral blood grafts predict acute GVHD development.

Donor-derived distinct neutrophil subsets in the G-CSF-mobilized peripheral blood grafts predict acute GVHD development.

Journal: Transplantation and cellular therapy

Published: March 11, 2026

Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia.

Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia.

Journal: Blood advances

Published: February 27, 2026

Long-term effects of multidisciplinary team recommendations on adult patients with acute myeloid leukemia.

Long-term effects of multidisciplinary team recommendations on adult patients with acute myeloid leukemia.

Journal: Bioscience trends

Published: February 08, 2026

Alternative donors, particularly haploidentical donors, are safe and effective for elderly patients with adverse-risk AML: a multicenter TROPHY study.

Alternative donors, particularly haploidentical donors, are safe and effective for elderly patients with adverse-risk AML: a multicenter TROPHY study.

Journal: Blood cancer journal

Published: December 25, 2025

CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD.

CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD.

Journal: Blood

Published: November 25, 2025

A randomized trial of GVHD prophylaxis in haploidentical PBSC transplantation: ATG, PTCy, and low-dose combination therapy.

A randomized trial of GVHD prophylaxis in haploidentical PBSC transplantation: ATG, PTCy, and low-dose combination therapy.

Journal: Blood

Published: November 25, 2025

Development and Validation of a Cytokine-Based Predictive Model for Acute GvHD and Composite Outcomes in ATG-Based Haploidentical Hematopoietic Stem Cell Transplantation.

Development and Validation of a Cytokine-Based Predictive Model for Acute GvHD and Composite Outcomes in ATG-Based Haploidentical Hematopoietic Stem Cell Transplantation.

Journal: Mediators of inflammation

Published: November 14, 2025

Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.

Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.

Journal: American journal of hematology

Published: October 05, 2025

Acute Myeloid Leukemia Patients With Myelodysplasia-Related Gene Mutations Benefit From Post-Transplant Hypomethylating Agent Maintenance.

Acute Myeloid Leukemia Patients With Myelodysplasia-Related Gene Mutations Benefit From Post-Transplant Hypomethylating Agent Maintenance.

Journal: Transplantation and cellular therapy

Published: October 03, 2025

Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms.

Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms.

Journal: Bone marrow transplantation

Published: September 19, 2025

Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies.

Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies.

Journal: Frontiers in cellular and infection microbiology

Published: August 03, 2025

Showing 1-12 of 41

Last Updated: 09/26/2026